Acute Intoxications Involving Synthetic Psychoactive Substances

The purpose of this study was to evaluate the effectiveness of a succinic acid derivate, a substrate metabolic agent cytoflavin in patients with acute poisoning with synthetic psychoactive drugs.Materials and methods. A retrospective evaluation of effectiveness of a combined intensive care treatment...

Full description

Bibliographic Details
Main Authors: Sergey A. Vasil'ev, Viktor V. Shilov, Pavel A. Barabanov, Valentin G. Sentsov, Boris B. Yatsinyuk
Format: Article
Language:Russian
Published: Russian Academy of Medical Sciences 2018-03-01
Series:Obŝaâ Reanimatologiâ
Subjects:
Online Access:https://www.reanimatology.com/rmt/article/view/1635
id doaj-1e2c493f9c4a472792da2030bb9a5592
record_format Article
spelling doaj-1e2c493f9c4a472792da2030bb9a55922021-07-28T21:21:56ZrusRussian Academy of Medical SciencesObŝaâ Reanimatologiâ1813-97792411-71102018-03-01141232810.15360/1813-9779-2018-1-23-281594Acute Intoxications Involving Synthetic Psychoactive SubstancesSergey A. Vasil'ev0Viktor V. Shilov1Pavel A. Barabanov2Valentin G. Sentsov3Boris B. Yatsinyuk4I. I. Mechnikov North-Western State Medical University, Ministry of Health of RussiaI. I. Mechnikov North-Western State Medical University, Ministry of Health of RussiaI. I. Mechnikov North-Western State Medical University, Ministry of Health of RussiaUral State Medical University, Ministry of Health of RussiaKhanty-Mansiysk State Medical Academy, Ministry of Health of RussiaThe purpose of this study was to evaluate the effectiveness of a succinic acid derivate, a substrate metabolic agent cytoflavin in patients with acute poisoning with synthetic psychoactive drugs.Materials and methods. A retrospective evaluation of effectiveness of a combined intensive care treatment protocol for 622 patients with acute narcotic poisoning (methadone and synthetic cannabinoids) was carried out. All patients were divided into two groups. The main group (112 patients, median age 38.2±12.0 years) included patients who, in addition to the basic treatment, received cytoflavin by intravenous drop infusion, 20–40 ml diluted in 400–500 ml of 10% glucose, for 5 days. Patients of the reference group (510 subjects, median age 37.6±14.1 years) received treatment according to the «classical scheme». In addition to conventional examination, all patients underwent duplex scanning of cerebral vessels, examination of changes in the cerebral blood circulation and electroencephalogram findings. The severity of somatic disorders was assessed using criteria of the Glasgow coma scale. The severity of the asthenic syndrome was assessed according to the MFI-20 scale.Results. Compared to patients who received a standard therapy, patients of the main group had a significantly more rapid recovery from coma (by 1.5-fold: 23.5±3.1 days, versus 15.1±3.0 days, respectively, P0.05); the duration of psychotic disorders was shorter (by 1.8-fold: 15.5±4.2 hours vs 8.3±2.5 hours., respectively, P0.05), and the intensity of asthenic syndrome (by 2.8-fold: 64.1±3.3 rel. units vs 23.0±4,9 rel. units, respectively, P0.05) was also lower.Conclusion. Inclusion of cytoflavin in a protocol of a complex treatment of patients with synthetic drugs poisoning increased the effectiveness of the therapy. Data demonstrate that inclusion of the drug can be recommended for treatment of acute synthetic narcotic poisoning.https://www.reanimatology.com/rmt/article/view/1635acute poisoningsynthetic narcoticsmethadonecannabinoidstherapynaloxonecytoflavin
collection DOAJ
language Russian
format Article
sources DOAJ
author Sergey A. Vasil'ev
Viktor V. Shilov
Pavel A. Barabanov
Valentin G. Sentsov
Boris B. Yatsinyuk
spellingShingle Sergey A. Vasil'ev
Viktor V. Shilov
Pavel A. Barabanov
Valentin G. Sentsov
Boris B. Yatsinyuk
Acute Intoxications Involving Synthetic Psychoactive Substances
Obŝaâ Reanimatologiâ
acute poisoning
synthetic narcotics
methadone
cannabinoids
therapy
naloxone
cytoflavin
author_facet Sergey A. Vasil'ev
Viktor V. Shilov
Pavel A. Barabanov
Valentin G. Sentsov
Boris B. Yatsinyuk
author_sort Sergey A. Vasil'ev
title Acute Intoxications Involving Synthetic Psychoactive Substances
title_short Acute Intoxications Involving Synthetic Psychoactive Substances
title_full Acute Intoxications Involving Synthetic Psychoactive Substances
title_fullStr Acute Intoxications Involving Synthetic Psychoactive Substances
title_full_unstemmed Acute Intoxications Involving Synthetic Psychoactive Substances
title_sort acute intoxications involving synthetic psychoactive substances
publisher Russian Academy of Medical Sciences
series Obŝaâ Reanimatologiâ
issn 1813-9779
2411-7110
publishDate 2018-03-01
description The purpose of this study was to evaluate the effectiveness of a succinic acid derivate, a substrate metabolic agent cytoflavin in patients with acute poisoning with synthetic psychoactive drugs.Materials and methods. A retrospective evaluation of effectiveness of a combined intensive care treatment protocol for 622 patients with acute narcotic poisoning (methadone and synthetic cannabinoids) was carried out. All patients were divided into two groups. The main group (112 patients, median age 38.2±12.0 years) included patients who, in addition to the basic treatment, received cytoflavin by intravenous drop infusion, 20–40 ml diluted in 400–500 ml of 10% glucose, for 5 days. Patients of the reference group (510 subjects, median age 37.6±14.1 years) received treatment according to the «classical scheme». In addition to conventional examination, all patients underwent duplex scanning of cerebral vessels, examination of changes in the cerebral blood circulation and electroencephalogram findings. The severity of somatic disorders was assessed using criteria of the Glasgow coma scale. The severity of the asthenic syndrome was assessed according to the MFI-20 scale.Results. Compared to patients who received a standard therapy, patients of the main group had a significantly more rapid recovery from coma (by 1.5-fold: 23.5±3.1 days, versus 15.1±3.0 days, respectively, P0.05); the duration of psychotic disorders was shorter (by 1.8-fold: 15.5±4.2 hours vs 8.3±2.5 hours., respectively, P0.05), and the intensity of asthenic syndrome (by 2.8-fold: 64.1±3.3 rel. units vs 23.0±4,9 rel. units, respectively, P0.05) was also lower.Conclusion. Inclusion of cytoflavin in a protocol of a complex treatment of patients with synthetic drugs poisoning increased the effectiveness of the therapy. Data demonstrate that inclusion of the drug can be recommended for treatment of acute synthetic narcotic poisoning.
topic acute poisoning
synthetic narcotics
methadone
cannabinoids
therapy
naloxone
cytoflavin
url https://www.reanimatology.com/rmt/article/view/1635
work_keys_str_mv AT sergeyavasilev acuteintoxicationsinvolvingsyntheticpsychoactivesubstances
AT viktorvshilov acuteintoxicationsinvolvingsyntheticpsychoactivesubstances
AT pavelabarabanov acuteintoxicationsinvolvingsyntheticpsychoactivesubstances
AT valentingsentsov acuteintoxicationsinvolvingsyntheticpsychoactivesubstances
AT borisbyatsinyuk acuteintoxicationsinvolvingsyntheticpsychoactivesubstances
_version_ 1721259668850868224